Mike Reardon joins the board of Vidant Pharma
This article was originally published in Scrip
Mike Reardon, chief executive of Xiota, has joined Vidant Pharma as a non-executive director. Vidant is about to launch its first product, Eradicil, a medicated laundry pre-wash that kills fungi and bacteria, onto the UK OTC pharmaceuticals market. The product, originally developed by Marion Merrell Dow (now part of Sanofi-Aventis), is already available in Europe as an adjunct to other treatments for dermatological infections.
You may also be interested in...
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.
Another failed study in Duchenne muscular dystrophy spells the end for edasalonexent and possibly the firm.
Phase II results look good for one of the first-in-class product’s potential indications, C3 glomerulopathy. The product was highlighted late last year as an up-and-coming pipeline asset.